DOTHAN, Ala. (WDHN) — Hospitals across the nation received doses of an experimental drug being used to help treat COVID-19.
Southeast Health was one of 33 hospitals in Alabama that received one five-day vial of Remdesivir.
There are five-day and a 10-day trial versions of the drug. Doctor Charles Harkness at Southeast Health said patients who are administered Remdesivir must meet extensive and specific requirements having to do with how sick the patients are, what treatments have been done, and possible reactions to the side effects,
“It’s an investigational drug,” chief medical officer Charles Harkness said. “We got one distribution of the drug a week ago, ended up not using it on a patient, and we don’t have any eligible or at least we didn’t. at the end of last week, have any eligible patients for the drug. It’s definitely not a cure drug, but the studies would suggest it may impact the length of illness for COVID-19.”
Remdesivir is created by Gilead Sciences.